UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Direct oral anticoagulants: evidence and unresolved issues

The Lancet (British edition), 2020-11, Vol.396 (10264), p.1767-1776

2020

Volltextzugriff (PDF)

Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease

Journal of the American College of Cardiology, 2013-01, Vol.61 (4), p.404-410

2013

Volltextzugriff (PDF)

A Test in Context: D-Dimer

Journal of the American College of Cardiology, 2017-11, Vol.70 (19), p.2411-2420

2017

Volltextzugriff (PDF)

Letter: Incidence and Predictors of Major Gastrointestinal Bleeding in Patients on Aspirin, Low-Dose Rivaroxaban or the Combination: Secondary Analysis of the COMPASS Randomised Controlled Trial. Authors' Reply

Alimentary pharmacology & therapeutics, 2024-10

2024

Volltextzugriff (PDF)

Factor XI inhibitors: cardiovascular perspectives

European heart journal, 2023-01, Vol.44 (4), p.280-292

2023

Volltextzugriff (PDF)

The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe?

Thrombosis and haemostasis, 2010-07, Vol.104 (1), p.45-48

2010

Volltextzugriff (PDF)

Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned

Circulation (New York, N.Y.), 2022-12, Vol.146 (23), p.1746-1748

2022

Volltextzugriff (PDF)

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

The Lancet (British edition), 2016-06, Vol.387 (10035), p.2302-2311

2016

Volltextzugriff (PDF)

Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease: Lessons From the COMPASS Trial

Circulation research, 2019-02, Vol.124 (3), p.416-425

2019

Volltextzugriff (PDF)

In healthy older adults, low-dose aspirin increased incident anemia at a median 4.7 y

Annals of internal medicine, 2023-10, Vol.176 (10), p.JC115

2023

Volltextzugriff (PDF)

P-Selectin de-ACTIVation in COVID-19: What Have We Learned?

Circulation (New York, N.Y.), 2023-08, Vol.148 (5), p.391-393

2023

Volltextzugriff (PDF)

Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion

The New England journal of medicine, 2016-11, Vol.375 (20), p.1937-1945

2016

Volltextzugriff (PDF)

Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism

The New England journal of medicine, 2012-11, Vol.367 (21), p.1979-1987

2012

Volltextzugriff (PDF)

Dabigatran Etexilate: A New Oral Thrombin Inhibitor

Circulation (New York, N.Y.), 2011-04, Vol.123 (13), p.1436-1450

2011

Volltextzugriff (PDF)

Laboratory measurement of the direct oral anticoagulants

British journal of haematology, 2016-02, Vol.172 (3), p.315-336

2016

Volltextzugriff (PDF)

Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors

Circulation (New York, N.Y.), 2023-03, Vol.147 (13), p.1026-1038

2023

Volltextzugriff (PDF)

The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)

Journal of the American College of Cardiology, 2014-02, Vol.63 (4), p.321-328

2014

Volltextzugriff (PDF)

Anticoagulant-Related Nephropathy

Journal of the American Society of Nephrology, 2018-12, Vol.29 (12), p.2787-2793

2018

Volltextzugriff (PDF)

External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry

European heart journal, 2018-03, Vol.39 (9), p.750-757a

2018

Volltextzugriff (PDF)

Direct oral anticoagulant dose selection: Challenging cases

Journal of thrombosis and haemostasis, 2021-11, Vol.19 (11), p.2680-2686

2021

Volltextzugriff (PDF)

Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration

Circulation (New York, N.Y.), 2014-09, Vol.130 (13), p.1062-1071

2014

Volltextzugriff (PDF)

Warfarin faring better: vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials

Journal of thrombosis and haemostasis, 2023-11, Vol.21 (11), p.3067-3071

2023

Volltextzugriff (PDF)

Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials

Thrombosis and haemostasis, 2014, Vol.112 (5), p.918-923

2014

Volltextzugriff (PDF)

Urgent Need to Measure Effects of Direct Oral Anticoagulants

Circulation (New York, N.Y.), 2016-07, Vol.134 (3), p.186-188

2016

Volltextzugriff (PDF)

Monitoring unfractionated heparin with the aPTT: time for a fresh look

Thrombosis and haemostasis, 2006-11, Vol.96 (5), p.547-552

2006

Volltextzugriff (PDF)

1 – 25 von 1.051

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.010)
Mit Volltextzugriff
(851)

Publikationsform

Artikel
(1.040)
Buchkapitel
(10)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(728)
Life Sciences & Biomedicine
(721)
Humans
(632)
Cardiovascular System & Cardiology
(442)
Cardiac & Cardiovascular Systems
(336)
Male
(292)
Female
(284)
Aged
(244)
Peripheral Vascular Disease
(205)
Stroke
(185)
Middle Aged
(177)
Anticoagulants
(176)
Biological And Medical Sciences
(169)
Medical Sciences
(168)
Risk Factors
(165)
Anticoagulants - Therapeutic Use
(162)
General & Internal Medicine
(158)
Medicine, General & Internal
(145)
Treatment Outcome
(145)
Atrial Fibrillation
(134)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Circulation
(106)
Journal Of The American College Of Cardiology
(101)
Thrombosis And Haemostasis
(45)
The Lancet
(44)
European Heart Journal
(42)
The New England Journal Of Medicine
(40)
Stroke
(38)
Medical Journal Of Australia
(30)
The American Heart Journal
(27)
Canadian Journal Of Cardiology
(25)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Direct oral anticoagulants: evidence and unresolved issues

Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease

A Test in Context: D-Dimer

Letter: Incidence and Predictors of Major Gastrointestinal Bleeding in Patients on Aspirin, Low-Dose Rivaroxaban or the Combination: Secondary Analysis of the COMPASS Randomised Controlled Trial. Authors' Reply

Factor XI inhibitors: cardiovascular perspectives

The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe?

Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease: Lessons From the COMPASS Trial

In healthy older adults, low-dose aspirin increased incident anemia at a median 4.7 y

P-Selectin de-ACTIVation in COVID-19: What Have We Learned?

Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion

Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism

Dabigatran Etexilate: A New Oral Thrombin Inhibitor

Laboratory measurement of the direct oral anticoagulants

Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors

The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)

Anticoagulant-Related Nephropathy

External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry

Direct oral anticoagulant dose selection: Challenging cases

Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration

Warfarin faring better: vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials

Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials

Urgent Need to Measure Effects of Direct Oral Anticoagulants

Monitoring unfractionated heparin with the aPTT: time for a fresh look

Suchergebnisse filtern